Class Action

Well at Walgreens Enhanced Absorption Formula CoQ-10

Class Action

Well at Walgreens Enhanced Absorption Formula CoQ-10

April 2015: The named plaintiffs voluntarily dismissed this action When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.. The reasons have not been disclosed.

January 2015: A class-action lawsuit was filed against Walgreens for allegedly falsely advertising the dietary supplement Well at Walgreens Enhanced Absorption Formula CoQ-10. Specifically, plaintiffs claim that the company falsely labels the supplement as having “enhanced absorption” when, in reality, the supplement does not meet the U.S. Pharmacopeial Convention’s minimum requirements to make such claims (The U.S. Pharmacopeial Convention is an organization that publishes testing standards in the drug and dietary supplement industries.) In addition, the complaint alleges that company’s claims that the supplement provides certain benefits – such as helping to support heart health – are false and misleading because the supplement does not meet the U.S. Pharmacopeial Convention’s minimum requirements for effective absorption and bioavailability. (Reynolds et al v. Walgreen Co., Case No. 15-cv-324, N. D. CA.).

For more information about class-action lawsuits filed against Walgreens and TINA.org’s coverage of the company, click here.

 


Class-Action Tracker

Walgreens Acne Products

Class Action

Walgreens Acne Products

Allegations: Misleadingly representing that products were safe when they contain, or were at risk of containing, the carcinogen benzene

Several Store Brand Acetaminophen Products

Class Action

Several Store Brand Acetaminophen Products

Allegations: Marketing products as safe pain relievers for pregnant women without warning consumers that scientific evidence shows prenatal exposure to APAP can cause neurodevelopmental disorders in children

Walgreens’ Infants’ Pain & Fever Acetaminophen

Class Action

Walgreens’ Infants’ Pain & Fever Acetaminophen

Allegations: Misleadingly marketing its infants’ product as specifically formulated for infants and different from its Children’s Pain & Fever Acetaminophen Oral Suspension when both medications contain the same amount and…


The Latest

Filters


Show More